The clinical spectrum of X-linked adrenoleukodystrophy: from Addison’s-only in men to middle-age neurologic manifestations in women View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-10-15

AUTHORS

Lúcia Fadiga, Miguel Melo, Joana Saraiva, Isabel Paiva

ABSTRACT

X-linked adrenoleukodystrophy (X-ALD) is caused by a mutation in the ABCD1 gene which encodes for a peroxisomal very long-chain fatty acid (VLCFA) transporter. Clinically, X-ALD can present a wide range of phenotypes, from slowly progressive myelopathy to rapid demyelination of brain white matter (cerebral X-ALD—CALD). Adrenocortical insufficiency (AI) occurs mainly in the pediatric age group, and it can be the first manifestation of the disease. Female carriers may also develop manifestations of myelopathy, but later in life. We present two cases of patients who show the heterogeneous clinical manifestations of X-ALD. Case 1 was a man with AI diagnosed at 6 years old and with the first manifestations of myelopathy at 44 years old, which led to the diagnosis of X-ALD. At 47 years, he developed rapidly progressive CALD. Case 2 was a woman with progressive spastic gait disturbance that started at 49 years old. The diagnosis of X-ALD was confirmed at 54 years old after the discovery of a family history of the disease. Mild progression of the neurologic manifestations was noted, but with no signs of AI nor CALD. She is currently 60 years old and under surveillance. We review the current knowledge on X-ALD as concerns its genetic and pathophysiological mechanisms, clinical presentations, diagnosis, treatment, and follow-up. This condition is a real diagnostic challenge. The early detection of AI and CALD, potentially life-threatening complications in men, is very difficult. The surveillance of these complications in female patients still raises controversy. More... »

PAGES

33-40

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s42000-021-00325-y

DOI

http://dx.doi.org/10.1007/s42000-021-00325-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1141916130

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34652632


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ATP Binding Cassette Transporter, Subfamily D, Member 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenoleukodystrophy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heterozygote", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, EPE, Coimbra, Portugal", 
          "id": "http://www.grid.ac/institutes/grid.28911.33", 
          "name": [
            "Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, EPE, Coimbra, Portugal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fadiga", 
        "givenName": "L\u00facia", 
        "id": "sg:person.011644533126.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011644533126.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Faculty of Medicine, University of Coimbra, Coimbra, Portugal", 
          "id": "http://www.grid.ac/institutes/grid.8051.c", 
          "name": [
            "Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, EPE, Coimbra, Portugal", 
            "Faculty of Medicine, University of Coimbra, Coimbra, Portugal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Melo", 
        "givenName": "Miguel", 
        "id": "sg:person.0741411065.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741411065.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Faculty of Medicine, University of Coimbra, Coimbra, Portugal", 
          "id": "http://www.grid.ac/institutes/grid.8051.c", 
          "name": [
            "Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, EPE, Coimbra, Portugal", 
            "Faculty of Medicine, University of Coimbra, Coimbra, Portugal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saraiva", 
        "givenName": "Joana", 
        "id": "sg:person.016671650723.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016671650723.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, EPE, Coimbra, Portugal", 
          "id": "http://www.grid.ac/institutes/grid.28911.33", 
          "name": [
            "Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universit\u00e1rio de Coimbra, EPE, Coimbra, Portugal"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paiva", 
        "givenName": "Isabel", 
        "id": "sg:person.01212776354.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212776354.48"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrneurol.2017.175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100195003", 
          "https://doi.org/10.1038/nrneurol.2017.175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13023-019-1184-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1121005849", 
          "https://doi.org/10.1186/s13023-019-1184-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1750-1172-7-51", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039469342", 
          "https://doi.org/10.1186/1750-1172-7-51"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13023-019-1008-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111989432", 
          "https://doi.org/10.1186/s13023-019-1008-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1750-1172-9-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033138911", 
          "https://doi.org/10.1186/1750-1172-9-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrendo.2016.90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028019216", 
          "https://doi.org/10.1038/nrendo.2016.90"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13311-019-00735-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1114037287", 
          "https://doi.org/10.1007/s13311-019-00735-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00314189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034773543", 
          "https://doi.org/10.1007/bf00314189"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-15", 
    "datePublishedReg": "2021-10-15", 
    "description": "X-linked adrenoleukodystrophy (X-ALD) is caused by a mutation in the ABCD1 gene which encodes for a peroxisomal very long-chain fatty acid (VLCFA) transporter. Clinically, X-ALD can present a wide range of phenotypes, from slowly progressive myelopathy to rapid demyelination of brain white matter (cerebral X-ALD\u2014CALD). Adrenocortical insufficiency (AI) occurs mainly in the pediatric age group, and it can be the first manifestation of the disease. Female carriers may also develop manifestations of myelopathy, but later in life. We present two cases of patients who show the heterogeneous clinical manifestations of X-ALD. Case 1 was a man with AI diagnosed at 6\u00a0years old and with the first manifestations of myelopathy at 44\u00a0years old, which led to the diagnosis of X-ALD. At 47\u00a0years, he developed rapidly progressive CALD. Case 2 was a woman with progressive spastic gait disturbance that started at 49\u00a0years old. The diagnosis of X-ALD was confirmed at 54\u00a0years old after the discovery of a family history of the disease. Mild progression of the neurologic manifestations was noted, but with no signs of AI nor CALD. She is currently 60\u00a0years old and under surveillance. We review the current knowledge on X-ALD as concerns its genetic and pathophysiological mechanisms, clinical presentations, diagnosis, treatment, and follow-up. This condition is a real diagnostic challenge. The early detection of AI and CALD, potentially life-threatening complications in men, is very difficult. The surveillance of these complications in female patients still raises controversy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s42000-021-00325-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1030758", 
        "issn": [
          "1109-3099", 
          "2520-8721"
        ], 
        "name": "Hormones", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "adrenocortical insufficiency", 
      "X-ALD", 
      "neurologic manifestations", 
      "first manifestation", 
      "progressive spastic gait disturbance", 
      "spastic gait disturbance", 
      "life-threatening complications", 
      "pediatric age group", 
      "real diagnostic challenge", 
      "cases of patients", 
      "heterogeneous clinical manifestations", 
      "rapid demyelination", 
      "progressive myelopathy", 
      "gait disturbance", 
      "long-chain fatty acid transporter", 
      "clinical presentation", 
      "female patients", 
      "clinical manifestations", 
      "brain white matter", 
      "mild progression", 
      "pathophysiological mechanisms", 
      "clinical spectrum", 
      "fatty acid transporters", 
      "diagnostic challenge", 
      "family history", 
      "ABCD1 gene", 
      "white matter", 
      "age groups", 
      "myelopathy", 
      "female carriers", 
      "Case 2", 
      "early detection", 
      "Case 1", 
      "diagnosis", 
      "manifestations", 
      "complications", 
      "patients", 
      "acid transporters", 
      "men", 
      "adrenoleukodystrophy", 
      "disease", 
      "CALD", 
      "women", 
      "current knowledge", 
      "surveillance", 
      "years", 
      "demyelination", 
      "insufficiency", 
      "progression", 
      "treatment", 
      "presentation", 
      "signs", 
      "phenotype", 
      "group", 
      "transporters", 
      "mutations", 
      "controversy", 
      "history", 
      "cases", 
      "genes", 
      "life", 
      "disturbances", 
      "mechanism", 
      "Addison", 
      "carriers", 
      "detection", 
      "knowledge", 
      "discovery", 
      "challenges", 
      "wide range", 
      "conditions", 
      "range", 
      "matter", 
      "spectra"
    ], 
    "name": "The clinical spectrum of X-linked adrenoleukodystrophy: from Addison\u2019s-only in men to middle-age neurologic manifestations in women", 
    "pagination": "33-40", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1141916130"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s42000-021-00325-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34652632"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s42000-021-00325-y", 
      "https://app.dimensions.ai/details/publication/pub.1141916130"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_877.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s42000-021-00325-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00325-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00325-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00325-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00325-y'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      22 PREDICATES      117 URIs      101 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s42000-021-00325-y schema:about N461e026536994e86a7c954693d451f4d
2 N686eedb1fc65405996f6e0c2b04ff6d6
3 N7a6506aa55ca4fe1b45601db39cc888d
4 N92efb970e14140009acb718383378b5f
5 N950c300c0cf849aea6eff0ecbecda3c2
6 Ncfdaeaa23d94439780a2eefa7d42f3f5
7 Ndbecb3eccdf34a768264334cab54725f
8 Ne994fb48a8554f149295493ac6462e81
9 Nf8bef31312014c1d8b1ff43fad3f05c8
10 anzsrc-for:11
11 anzsrc-for:1109
12 schema:author N19bf9cccbb464fcc913f850363d405cd
13 schema:citation sg:pub.10.1007/bf00314189
14 sg:pub.10.1007/s13311-019-00735-2
15 sg:pub.10.1038/nrendo.2016.90
16 sg:pub.10.1038/nrneurol.2017.175
17 sg:pub.10.1186/1750-1172-7-51
18 sg:pub.10.1186/1750-1172-9-6
19 sg:pub.10.1186/s13023-019-1008-6
20 sg:pub.10.1186/s13023-019-1184-4
21 schema:datePublished 2021-10-15
22 schema:datePublishedReg 2021-10-15
23 schema:description X-linked adrenoleukodystrophy (X-ALD) is caused by a mutation in the ABCD1 gene which encodes for a peroxisomal very long-chain fatty acid (VLCFA) transporter. Clinically, X-ALD can present a wide range of phenotypes, from slowly progressive myelopathy to rapid demyelination of brain white matter (cerebral X-ALD—CALD). Adrenocortical insufficiency (AI) occurs mainly in the pediatric age group, and it can be the first manifestation of the disease. Female carriers may also develop manifestations of myelopathy, but later in life. We present two cases of patients who show the heterogeneous clinical manifestations of X-ALD. Case 1 was a man with AI diagnosed at 6 years old and with the first manifestations of myelopathy at 44 years old, which led to the diagnosis of X-ALD. At 47 years, he developed rapidly progressive CALD. Case 2 was a woman with progressive spastic gait disturbance that started at 49 years old. The diagnosis of X-ALD was confirmed at 54 years old after the discovery of a family history of the disease. Mild progression of the neurologic manifestations was noted, but with no signs of AI nor CALD. She is currently 60 years old and under surveillance. We review the current knowledge on X-ALD as concerns its genetic and pathophysiological mechanisms, clinical presentations, diagnosis, treatment, and follow-up. This condition is a real diagnostic challenge. The early detection of AI and CALD, potentially life-threatening complications in men, is very difficult. The surveillance of these complications in female patients still raises controversy.
24 schema:genre article
25 schema:inLanguage en
26 schema:isAccessibleForFree false
27 schema:isPartOf N8eff4ec39c5d48d7855b216f6242f00f
28 Nf627a4e53efb47389c317515e3b38c87
29 sg:journal.1030758
30 schema:keywords ABCD1 gene
31 Addison
32 CALD
33 Case 1
34 Case 2
35 X-ALD
36 acid transporters
37 adrenocortical insufficiency
38 adrenoleukodystrophy
39 age groups
40 brain white matter
41 carriers
42 cases
43 cases of patients
44 challenges
45 clinical manifestations
46 clinical presentation
47 clinical spectrum
48 complications
49 conditions
50 controversy
51 current knowledge
52 demyelination
53 detection
54 diagnosis
55 diagnostic challenge
56 discovery
57 disease
58 disturbances
59 early detection
60 family history
61 fatty acid transporters
62 female carriers
63 female patients
64 first manifestation
65 gait disturbance
66 genes
67 group
68 heterogeneous clinical manifestations
69 history
70 insufficiency
71 knowledge
72 life
73 life-threatening complications
74 long-chain fatty acid transporter
75 manifestations
76 matter
77 mechanism
78 men
79 mild progression
80 mutations
81 myelopathy
82 neurologic manifestations
83 pathophysiological mechanisms
84 patients
85 pediatric age group
86 phenotype
87 presentation
88 progression
89 progressive myelopathy
90 progressive spastic gait disturbance
91 range
92 rapid demyelination
93 real diagnostic challenge
94 signs
95 spastic gait disturbance
96 spectra
97 surveillance
98 transporters
99 treatment
100 white matter
101 wide range
102 women
103 years
104 schema:name The clinical spectrum of X-linked adrenoleukodystrophy: from Addison’s-only in men to middle-age neurologic manifestations in women
105 schema:pagination 33-40
106 schema:productId N1df2234ea7f7468b9c1661b436dae4f8
107 Na9dcefd21695427095025d071379bc0b
108 Nebf0a85e7a2340998699dd146d1a4f7d
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141916130
110 https://doi.org/10.1007/s42000-021-00325-y
111 schema:sdDatePublished 2022-05-20T07:38
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N2598759fb13340969624ca8b7cfca7b9
114 schema:url https://doi.org/10.1007/s42000-021-00325-y
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N19bf9cccbb464fcc913f850363d405cd rdf:first sg:person.011644533126.95
119 rdf:rest N36c24c6fd6ba4f1d868da710ec45b88d
120 N1df2234ea7f7468b9c1661b436dae4f8 schema:name dimensions_id
121 schema:value pub.1141916130
122 rdf:type schema:PropertyValue
123 N2598759fb13340969624ca8b7cfca7b9 schema:name Springer Nature - SN SciGraph project
124 rdf:type schema:Organization
125 N2cac12f8cb2b40e5bcc7718738a92889 rdf:first sg:person.01212776354.48
126 rdf:rest rdf:nil
127 N36c24c6fd6ba4f1d868da710ec45b88d rdf:first sg:person.0741411065.88
128 rdf:rest Nd75307aaad364279a968f3468185a61a
129 N461e026536994e86a7c954693d451f4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Mutation
131 rdf:type schema:DefinedTerm
132 N686eedb1fc65405996f6e0c2b04ff6d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Adrenoleukodystrophy
134 rdf:type schema:DefinedTerm
135 N7a6506aa55ca4fe1b45601db39cc888d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Heterozygote
137 rdf:type schema:DefinedTerm
138 N8eff4ec39c5d48d7855b216f6242f00f schema:issueNumber 1
139 rdf:type schema:PublicationIssue
140 N92efb970e14140009acb718383378b5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 N950c300c0cf849aea6eff0ecbecda3c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Male
145 rdf:type schema:DefinedTerm
146 Na9dcefd21695427095025d071379bc0b schema:name doi
147 schema:value 10.1007/s42000-021-00325-y
148 rdf:type schema:PropertyValue
149 Ncfdaeaa23d94439780a2eefa7d42f3f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Phenotype
151 rdf:type schema:DefinedTerm
152 Nd75307aaad364279a968f3468185a61a rdf:first sg:person.016671650723.80
153 rdf:rest N2cac12f8cb2b40e5bcc7718738a92889
154 Ndbecb3eccdf34a768264334cab54725f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Female
156 rdf:type schema:DefinedTerm
157 Ne994fb48a8554f149295493ac6462e81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Child
159 rdf:type schema:DefinedTerm
160 Nebf0a85e7a2340998699dd146d1a4f7d schema:name pubmed_id
161 schema:value 34652632
162 rdf:type schema:PropertyValue
163 Nf627a4e53efb47389c317515e3b38c87 schema:volumeNumber 21
164 rdf:type schema:PublicationVolume
165 Nf8bef31312014c1d8b1ff43fad3f05c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name ATP Binding Cassette Transporter, Subfamily D, Member 1
167 rdf:type schema:DefinedTerm
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
172 schema:name Neurosciences
173 rdf:type schema:DefinedTerm
174 sg:journal.1030758 schema:issn 1109-3099
175 2520-8721
176 schema:name Hormones
177 schema:publisher Springer Nature
178 rdf:type schema:Periodical
179 sg:person.011644533126.95 schema:affiliation grid-institutes:grid.28911.33
180 schema:familyName Fadiga
181 schema:givenName Lúcia
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011644533126.95
183 rdf:type schema:Person
184 sg:person.01212776354.48 schema:affiliation grid-institutes:grid.28911.33
185 schema:familyName Paiva
186 schema:givenName Isabel
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212776354.48
188 rdf:type schema:Person
189 sg:person.016671650723.80 schema:affiliation grid-institutes:grid.8051.c
190 schema:familyName Saraiva
191 schema:givenName Joana
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016671650723.80
193 rdf:type schema:Person
194 sg:person.0741411065.88 schema:affiliation grid-institutes:grid.8051.c
195 schema:familyName Melo
196 schema:givenName Miguel
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741411065.88
198 rdf:type schema:Person
199 sg:pub.10.1007/bf00314189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034773543
200 https://doi.org/10.1007/bf00314189
201 rdf:type schema:CreativeWork
202 sg:pub.10.1007/s13311-019-00735-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1114037287
203 https://doi.org/10.1007/s13311-019-00735-2
204 rdf:type schema:CreativeWork
205 sg:pub.10.1038/nrendo.2016.90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028019216
206 https://doi.org/10.1038/nrendo.2016.90
207 rdf:type schema:CreativeWork
208 sg:pub.10.1038/nrneurol.2017.175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100195003
209 https://doi.org/10.1038/nrneurol.2017.175
210 rdf:type schema:CreativeWork
211 sg:pub.10.1186/1750-1172-7-51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039469342
212 https://doi.org/10.1186/1750-1172-7-51
213 rdf:type schema:CreativeWork
214 sg:pub.10.1186/1750-1172-9-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033138911
215 https://doi.org/10.1186/1750-1172-9-6
216 rdf:type schema:CreativeWork
217 sg:pub.10.1186/s13023-019-1008-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111989432
218 https://doi.org/10.1186/s13023-019-1008-6
219 rdf:type schema:CreativeWork
220 sg:pub.10.1186/s13023-019-1184-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1121005849
221 https://doi.org/10.1186/s13023-019-1184-4
222 rdf:type schema:CreativeWork
223 grid-institutes:grid.28911.33 schema:alternateName Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal
224 schema:name Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal
225 rdf:type schema:Organization
226 grid-institutes:grid.8051.c schema:alternateName Faculty of Medicine, University of Coimbra, Coimbra, Portugal
227 schema:name Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal
228 Faculty of Medicine, University of Coimbra, Coimbra, Portugal
229 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...